×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OPGN – opgen inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OPGN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
02:12 am
opgn
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/11
02:03 am
opgn
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/3
03:32 am
opgn
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/25
03:38 am
opgn
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/17
03:02 am
opgn
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/9
02:07 am
opgn
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/1
02:06 am
opgn
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/24
02:08 am
opgn
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/19
04:34 pm
opgn
Form 4 OPGEN INC For: Dec 04 Filed by: Azudin Mohd Azham
Low
Report
Form 4 OPGEN INC For: Dec 04 Filed by: Azudin Mohd Azham
12/19
04:34 pm
opgn
Form 4 OPGEN INC For: Nov 06 Filed by: Chua Kok Hoe Victor
Low
Report
Form 4 OPGEN INC For: Nov 06 Filed by: Chua Kok Hoe Victor
12/19
04:34 pm
opgn
Form 4 OPGEN INC For: Nov 06 Filed by: Wong Poh Yin Constance
Low
Report
Form 4 OPGEN INC For: Nov 06 Filed by: Wong Poh Yin Constance
12/19
04:33 pm
opgn
Form 4 OPGEN INC For: Nov 06 Filed by: Low Yu Jie Ethan
Low
Report
Form 4 OPGEN INC For: Nov 06 Filed by: Low Yu Jie Ethan
12/19
04:33 pm
opgn
Form 4 OPGEN INC For: Nov 06 Filed by: Lim Zhao Qi Ken
Low
Report
Form 4 OPGEN INC For: Nov 06 Filed by: Lim Zhao Qi Ken
12/19
04:33 pm
opgn
Form 4 OPGEN INC For: Nov 06 Filed by: Bonte Christian-Laurent
Low
Report
Form 4 OPGEN INC For: Nov 06 Filed by: Bonte Christian-Laurent
12/19
04:33 pm
opgn
Form 4 OPGEN INC For: Dec 04 Filed by: Yee Gillian Tan Rou
Low
Report
Form 4 OPGEN INC For: Dec 04 Filed by: Yee Gillian Tan Rou
12/19
04:32 pm
opgn
Form 3 OPGEN INC For: Aug 09 Filed by: Low Yu Jie Ethan
Low
Report
Form 3 OPGEN INC For: Aug 09 Filed by: Low Yu Jie Ethan
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
OpGen Provides Update on Curetis Now Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe
41.3%
9/3 Form 4 OPGEN INC For: Sep 02 Filed by: Ushio Misti 19.3%
3/19 OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis 16.5%
6/13 OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection 15.9%
11/6 OpGen, Inc. (OPGN) CEO Evan Jones on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 13.8%
1/24 Form EFFECT OPGEN INC 13.2%
5/19 OpGen Inc (NASDAQ: OPGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $1.50 price target on the stock. 11.7%
2/28 Form 8-K OPGEN INC For: Feb 24 9.6%
4/10 Form 3 OPGEN INC For: Apr 01 Filed by: Bacher Johannes 9.1%
10/17 Form S-1/A OPGEN INC 8.3%
9/3 Form 4 OPGEN INC For: Sep 02 Filed by: Ushio Misti 19.3%
3/19 OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis 16.5%
6/13 OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection 15.9%
11/6 OpGen, Inc. (OPGN) CEO Evan Jones on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 13.8%
1/24 Form EFFECT OPGEN INC 13.2%
5/19 OpGen Inc (NASDAQ: OPGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $1.50 price target on the stock. 11.7%
2/28 Form 8-K OPGEN INC For: Feb 24 9.6%
4/10 Form 3 OPGEN INC For: Apr 01 Filed by: Bacher Johannes 9.1%
10/17 Form S-1/A OPGEN INC 8.3%
TOP News Decliners
10/23
OpGen Announces Pricing of $9.4 Million Underwritten Offering
-52.2%
10/23 U.S. Patent Allowed Covering Acuitas Lighthouse® Software -38.5%
8/7 Q2/2019 6/30/2019 EPS -0.150 ZacksConsensus -0.160 ActVsEst 0.010 - Beat -24.6%
10/15 Form S-1/A OPGEN INC -23.5%
3/16 Nano-Cap OpGen Skyrockets On COVID-19 Connection [Yahoo! Finance News] -22.4%
3/10 Curetis N.V. Shareholders Approve Planned Business Combination with OpGen -19.4%
1/28 OpGen Achieves Key Milestone in Planned Business Combination with Curetis -16.2%
3/18 Form 424B5 OPGEN INC -14.2%
4/21 OpGen Subsidiary Curetis GmbH and Karolinska Institutet Collaborate in Study of Bacterial Co-Infections in COVID-19 Pneumonia Patients -13.8%
3/3 Form 425 OPGEN INC Filed by: OPGEN INC -13.2%
10/23 U.S. Patent Allowed Covering Acuitas Lighthouse® Software -38.5%
8/7 Q2/2019 6/30/2019 EPS -0.150 ZacksConsensus -0.160 ActVsEst 0.010 - Beat -24.6%
10/15 Form S-1/A OPGEN INC -23.5%
3/16 Nano-Cap OpGen Skyrockets On COVID-19 Connection [Yahoo! Finance News] -22.4%
3/10 Curetis N.V. Shareholders Approve Planned Business Combination with OpGen -19.4%
1/28 OpGen Achieves Key Milestone in Planned Business Combination with Curetis -16.2%
3/18 Form 424B5 OPGEN INC -14.2%
4/21 OpGen Subsidiary Curetis GmbH and Karolinska Institutet Collaborate in Study of Bacterial Co-Infections in COVID-19 Pneumonia Patients -13.8%
3/3 Form 425 OPGEN INC Filed by: OPGEN INC -13.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: